Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in MYRIAD GENETICS INC
BNP PARIBAS FINANCIAL MARKETS holds 362,692 shares of MYGN (MYRIAD GENETICS INC), worth $1.6M as of 2026-Q1. The position was increased (+18.9% shares). MYGN represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$1.6M
Current Shares
362,692
Total Value Change
+$410,826
Total Shares Change
+312,762
Other major holders of MYGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 362,692 |
+18.9% |
| $1.6M |
| 0.0% |
| $5.29 |
30 |
| 2025-Q4 | Decreased | 304,974 | -20.7% | $1.9M | 0.0% | $6.17 | 0 |
| 2025-Q3 | Increased | 384,687 | +48.5% | $2.8M | 0.0% | $7.24 | 36 |
| 2025-Q2 | Increased | 259,011 | +118.9% | $1.4M | 0.0% | $5.25 | 41 |
| 2025-Q1 | Increased | 118,305 | +71.0% | $1M | 0.0% | $8.88 | 37 |
| 2024-Q4 | Increased | 69,183 | +51.1% | $948,499 | 0.0% | $13.63 | 35 |
| 2024-Q3 | Decreased | 45,775 | -8.3% | $1.3M | 0.0% | $26.46 | 0 |
| 2024-Q2 | Decreased | 49,930 | -33.0% | $1.2M | 0.0% | $24.46 | 0 |